Drug Database
Back to search

Canada· CA-DIN-01942425

VISINE ORIGINAL

A tetryzoline product containing tetrahydrozoline hydrochloride, registered in Canada by JOHNSON & JOHNSON INC. The same ATC class is registered in 6 of our 19 countries.

ATC S01GA02

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedVISINE ORIGINALATCS01GA02REGISTER NO.CA-DIN-01942425PACKS LISTED0CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tetrahydrozoline hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tetryzoline is registered in 6 of 19 countries.

Countries holding a registration under ATC S01GA02 (tetryzoline), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 5 of them publish a price we can compare per daily dose
Search tetryzoline products by name

Tetryzoline · ATC S01GA02

6 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
TETRAHYDROZOLINE HYDROCHLORIDE
Manufacturer
JOHNSON & JOHNSON INC
Country
Canada (CA)
ATC code
S01GA02
ATC class
Tetryzoline
Defined daily dose
62.5 mcg, AT
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

53 interactions on record for tetryzoline.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tetryzoline against other medicinesHow interaction checks work

Tetryzoline · interactions on record

53 records

  • 7 severe
  • 46 moderate

Most severe, free to view

  • MethylergometrineG02AB01severe
  • ErgometrineG02AB03severe
  • DihydroergotamineN02CA01severe
  • ErgotamineN02CA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tetryzoline in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tetryzoline products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Bulgaria · Визин Ново, Сенсилукс
  • Cyprus · Vispring Advance
  • Czechia · Visine Rapid
  • Germany · Berberil N, Berberil N Edo
  • Estonia · Visine
  • Spain · Optispring, Vispring
  • Finland · Oftan Starine
  • Greece · Vispring Advance
  • Croatia · Viset, Visiklear
  • Hungary · Visine Rapid, Vizored
  • Italy · Octilia, Stilla Decongestionante
  • Lithuania · Visine
  • Luxembourg · Berberil N, Berberil N Edo
  • Latvia · Visine
  • Poland · Starazolin, Starazolin Free
  • Portugal · Visine
  • Romania · Visine Novo
  • Slovenia · Neored Kapljice Za Oko, Visiklear
  • Slovakia · Sensilux, Visine Rapid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2389e4d8-4833-4fa9-b1c6-94252ee2a70f
GET /v1/drugs/2389e4d8-4833-4fa9-b1c6-94252ee2a70f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "01942425",
  "form": "DROPS",
  "class": "Human",
  "routes": [
    "OPHTHALMIC"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "S01GA02",
  "schedule": [
    "OTC"
  ],
  "drug_code": "42015",
  "strengths": [
    "0.05 %"
  ],
  "ahfs_class": null,
  "substances": [
    "TETRAHYDROZOLINE HYDROCHLORIDE"
  ],
  "product_categorization": null
}
API referenceMCP serverPlans

See everything about tetryzoline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console